A drug with the SMILES CC(C(=O)NC1CCCC1)N(C(=O)c1snc(C(N)=O)c1N)c1ccc2c(c1)OCCO2 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -19.332%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CC(C(=O)NC1CCCC1)N(C(=O)c1snc(C(N)=O)c1N)c1ccc2c(c1)OCCO2
CC(C(=O)NC1CCCC1)N(C(=O)c1snc(C(N)=O)c1N)c1ccc2c(c1)OCCO2
4-amino-5-N-[1-(cyclopentylamino)-1-oxopropan-2-yl]-5-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,2-thiazole-3,5-dicarboxamide